Drugs / EndostarTM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02489409 | Oct 2015 → May 2018 | breast cancer | Xinjiang Medical University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EndostarTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02489409 ↗ |